Novonesis (Novozymes) B's cash flow for dividends for the
three
months ended in Mar. 2026 was MXN-5,527 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-14,246 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
Novonesis (Novozymes) B's quarterly payment of dividends
declined
from Sep. 2025 (MXN-3,021 Mil) to Dec. 2025 (MXN0 Mil) but then
increased
from Dec. 2025 (MXN0 Mil) to Mar. 2026 (MXN-5,527 Mil).
Novonesis (Novozymes) B's annual payment of dividends
declined
from Dec. 2023 (MXN-7,093 Mil) to Dec. 2024 (MXN-5,455 Mil) but then
increased
from Dec. 2024 (MXN-5,455 Mil) to Dec. 2025 (MXN-8,491 Mil).
Novonesis (Novozymes) B Cash Flow for Dividends Related Terms
Novonesis (Novozymes) B Cash Flow for Dividends Historical Data
* Premium members only.
The historical data trend for Novonesis (Novozymes) B's Cash Flow for Dividends can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novonesis (Novozymes) B Cash Flow for Dividends Chart
Novonesis (Novozymes) B Cash Flow for Dividends Calculation
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-14,246 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow for Dividends of MXN-14,246 Mil mean?
Novonesis (Novozymes) B (MEX:NSISN) has a Cash Flow for Dividends of MXN-14,246 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Novonesis (Novozymes) B and its competitors.
Is Novonesis (Novozymes) B's Cash Flow for Dividends too high?
Novonesis (Novozymes) B's current Cash Flow for Dividends is MXN-14,246 Mil. Overall, Novonesis (Novozymes) B has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Novonesis (Novozymes) B's Cash Flow for Dividends compare to LIN and SHW?
Novonesis (Novozymes) B's Cash Flow for Dividends of MXN-14,246 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Chemicals company?
A good Cash Flow for Dividends depends on the Chemicals industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Novonesis (Novozymes) B and its competitors. Novonesis (Novozymes) B's current Cash Flow for Dividends is MXN-14,246 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novonesis (Novozymes) B stock overvalued right now?
Novonesis (Novozymes) B (MEX:NSISN) has a current Cash Flow for Dividends of MXN-14,246 Mil. The stock's GF Value™ is MXN979.45, compared to a current price of MXN911.11 — trading 7% below its estimated fair value. The current Cash Flow for Dividends is MXN-14,246 Mil. Novonesis (Novozymes) B's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Novonesis (Novozymes) B (MEX:NSISN), the current Cash Flow for Dividends is MXN-14,246 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novonesis (Novozymes) B (MEX:NSISN) Overvalued in 2026?
Based on GuruFocus' analysis, Novonesis (Novozymes) B stock appears to be undervalued.
The current stock price of MXN911.11 is trading 7% below its estimated GF Value™ of MXN979.45.
Key valuation signals for MEX:NSISN:
Cash Flow for Dividends: MXN-14,246 Mil
GF Value™: MXN979.45 vs. price of MXN911.11 (7% below fair value)
No single metric tells the full story. See the MEX:NSISN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
91GF Score
Get the complete analysis for MEX:NSISN
Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NSISN has been successfully added to your 
